Dongsung Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dongsung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanall Biopharma Company Limited
sales of 82.88 billion Korean Won [US$74.34 million]
of which 100%
was Medicinals and Bontanicals),
JW Shinyak Corp
(83.38 billion Korean Won [US$74.80 million]
Binex Company Ltd
(81.36 billion Korean Won [US$72.98 million]
of which 73%
Dongsung Pharmaceutical Company Limited reported sales of 79.72 billion Korean Won (US$71.51 million)
December of 2016.
increase of 6.8%
versus 2015, when the company's sales were 74.66 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Dongsung Pharmaceutical Company Limited had sales
of 78.44 billion Korean Won.
Sales of Pharmaceutical Segment saw an increase
10.3% in 2016, from
64.08 billion Korean Won to 70.70 billion Korean Won.
Not all segments of Dongsung Pharmaceutical Company Limited experienced an increase in sales in 2016:
sales of Cosmetics/toilet Preparation Segment fell 14.8% to 9.02 billion Korean Won.